BRAIN CANCER

Latest News

FDA Orphan Drug Status Granted for CAR T-Cell Therapy in Malignant Gliomas
FDA Orphan Drug Status Granted for CAR T-Cell Therapy in Malignant Gliomas

July 8th 2025

FDA designates MB-101 CAR T-cell therapy for glioblastoma, highlighting its potential in treating aggressive brain tumors with innovative combination strategies.

Novel Acoustic Coupling Fluid Earns FDA Breakthrough Status for Enhanced Neurosurgical Imaging
Novel Acoustic Coupling Fluid Earns FDA Breakthrough Status for Enhanced Neurosurgical Imaging

July 2nd 2025

PHOX2B PC-CAR T Enters Human Trials Following FDA IND Approval
PHOX2B PC-CAR T Enters Human Trials Following FDA IND Approval

June 16th 2025

Novel CAR T Earns FDA RMAT Designation for Incurable Pediatric Brain Tumor
Novel CAR T Earns FDA RMAT Designation for Incurable Pediatric Brain Tumor

May 15th 2025